BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Tag: Ovary › Expression data from breast cancer FNA biopsies from patients

Dataset: Expression data from breast cancer FNA biopsies from patients

We assess if distinct biological processes might be associated with chemotherapy sensitivity in the different clinical subsets of breast...

Registered by ArrayExpress Uploader
View Dataset

We assess if distinct biological processes might be associated with chemotherapy sensitivity in the different clinical subsets of breast cancers. We performed gene set analysis (GSA) using functionally annotated gene sets corresponding to almost all known biological processes in ER-positive/HER2negative and ER-negative/HER2-negative breast cancer, respectively. Pre-treatment FNA from primary tumors were obtained and RNA extracted and hybridized to afymetrix microarrays according to manufacturer protocol.

Species:
human

Samples:
82

Source:
E-GEOD-22093

Updated:
Dec.12, 2014

Registered:
Jun.24, 2014


Factors: (via ArrayExpress)
Sample PCR.V.RD PRECHEMO T AGE PRECHEMO TUMOR SIZE BMN.GRADE PRECHEMO N ER STATUS
GSM5493 RD 3 35 NA NA 1 ERneg
GSM549310 RD 3 36 NA NA 2 ERneg
GSM549309 RD 4 40 3.3 NA 0 ERneg
GSM549308 pCR 4 46 0 NA 2 ERpos
GSM549307 RD 4 52 0 NA 1 ERpos
GSM549306 pCR 4 43 0 NA 2 ERpos
GSM549305 RD 4 62 7 NA 2 ERpos
GSM549304 RD 4 43 7 NA 1 ERpos
GSM549303 RD 4 34 NA NA 1 ERneg
GSM549302 RD 3 36 4 NA 0 ERpos
GSM54930 RD 3 57 3.8 NA 1 ERpos
GSM549300 RD 4 52 2.3 NA 2 ERpos
GSM549299 RD 3 42 2.8 NA 0 ERpos
GSM549298 RD 2 57 1.1 2 0 ERneg
GSM549297 RD 2 49 0.19 2 0 ERpos
GSM549296 RD 2 38 1.3 3 1 ERneg
GSM549295 RD 2 34 2 2 2 ERpos
GSM549294 RD 4 53 3.5 2 1 ERpos
GSM549293 RD 2 32 0.5 3 2 ERpos
GSM549292 RD 2 62 2.5 2 0 ERpos
GSM54929 RD 4 58 5 3 2 ERneg
GSM549290 pCR 2 32 2 NA 1 ERneg
GSM549289 RD 4 46 3 3 2 ERneg
GSM549288 RD 2 43 1.2 2 1 ERpos
GSM549287 RD 3 31 3 3 1 ERneg
GSM549286 pCR 2 54 0 2 0 ERpos
GSM549285 RD 2 64 4 2 0 ERpos
GSM549284 RD 1 44 0 3 2 ERpos
GSM549283 RD 2 65 0.9 2 0 ERpos
GSM549282 RD 2 66 2 3 0 ERneg
GSM54928 RD 2 55 2 2 1 ERpos
GSM549280 RD 2 50 3.8 2 3 ERpos
GSM549279 RD 4 50 3.5 2 0 ERpos
GSM549278 RD 2 52 0.47 2 0 ERneg
GSM549277 RD 2 40 1 2 0 ERpos
GSM549276 RD 1 45 3 1 1 ERpos
GSM549275 RD 1 40 1.6 NA 1 ERpos
GSM549274 RD 4 78 3.2 3 1 ERpos
GSM549273 RD 3 46 5.5 NA 3 ERneg
GSM549272 RD 2 73 1.3 NA 0 ERpos
GSM54927 RD 3 45 2.5 3 0 ERneg
GSM549270 RD 2 68 1.8 2 0 ERpos
GSM549269 RD 3 49 2.5 1 0 ERpos
GSM549268 RD 2 51 2 1 0 ERpos
GSM549267 pCR 2 33 0 3 0 ERneg
GSM549266 RD 2 51 1.5 3 1 ERpos
GSM549265 RD 2 55 4.5 3 0 ERneg
GSM549264 pCR 2 66 NA 3 NA ERpos
GSM549263 pCR 2 53 NA 3 NA ERneg
GSM549262 RD 2 67 NA 2 NA ERneg
GSM54926 RD 2 39 NA 2 NA ERpos
GSM549260 RD 2 45 NA 3 NA ERneg
GSM549259 pCR 3 46 NA 2 NA ERpos
GSM549258 pCR 2 47 NA 3 NA ERpos
GSM549257 pCR 2 54 NA 3 NA ERneg
GSM549256 pCR 2 47 NA 3 NA ERneg
GSM549255 pCR 3 43 NA 2 NA ERneg
GSM549254 pCR 3 38 NA 3 NA ERneg
GSM549253 pCR 2 55 NA 3 NA ERneg
GSM549252 pCR 2 32 NA 3 NA ERneg
GSM54925 pCR 2 37 NA 3 NA ERneg
GSM549250 RD 3 38 NA 3 NA ERneg
GSM549249 RD 2 60 NA 3 NA ERneg
GSM549248 RD 3 55 NA 2 NA ERneg
GSM549247 RD 2 34 NA 2 NA ERpos
GSM549246 RD 3 38 NA 2 NA ERneg
GSM549245 RD 2 32 NA 3 NA ERneg
GSM549260 RD 2 45 NA 3 NA ERneg
GSM549243 RD 2 43 NA 2 NA ERpos
GSM549242 pCR 2 57 NA 3 NA ERneg
GSM549243 RD 2 43 NA 2 NA ERpos
GSM549240 pCR 4 31 NA 2 NA ERpos
GSM549239 RD 2 55 NA 3 NA ERpos
GSM549238 pCR 2 50 NA 3 NA ERneg
GSM549237 pCR 3 75 NA 3 NA ERneg
GSM549236 pCR 2 45 NA 3 NA ERneg
GSM549235 RD 2 50 NA 3 NA ERpos
GSM549234 RD 3 50 NA 3 NA ERneg
GSM549233 RD 3 52 NA 3 NA ERneg
GSM549232 pCR 3 62 NA 3 NA ERneg
GSM54923 pCR 3 52 NA 3 NA ERneg
GSM549230 pCR 3 55 NA 3 NA ERneg

Tags

  • breast
  • breast cancer
  • cancer

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use